Valuation: BioNexus Gene Lab Corp.

Market Cap 4.62M 4.04M 3.73M 3.45M 6.54M 441M 6.66M 44.73M 17.4M 216M 17.33M 16.96M 750M P/E 2024
-3.12x
P/E 2025 -2.46x
Enterprise Value 803K 703K 649K 600K 1.14M 76.71M 1.16M 7.78M 3.03M 37.62M 3.01M 2.95M 131M EV / Sales 2024
0.09x
EV / Sales 2025 0.74x
Free-Float
64.41%
Yield 2024 *
-
Yield 2025 -
1 day+1.05%
1 week-1.03%
Current month-1.03%
1 month-12.27%
3 months-16.12%
6 months-51.87%
Current year-51.14%
1 week 1.81
Extreme 1.81
2.12
1 month 1.07
Extreme 1.07
2.7
Current year 1.07
Extreme 1.07
4.14
1 year 1.07
Extreme 1.07
8.98
3 years 1.07
Extreme 1.07
178.8
5 years 1.07
Extreme 1.07
270
10 years 1.07
Extreme 1.07
414
Manager TitleAgeSince
Chief Executive Officer 43 2023-12-10
Director of Finance/CFO 63 2025-06-16
Director TitleAgeSince
Director/Board Member 71 2022-03-06
Director/Board Member 43 2023-12-10
Director/Board Member 51 2023-12-10
Date Insider Type Main position Quantity % Market Cap.
23-07-18Other

Chief Operating Officer

12,500,460 -
23-07-18Other

Chief Financial Officer

4,797,709 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%-1.03%-67.45%-96.26% 4.62M
-0.24%+4.98%+2.69%+9.14% 49.74B
-0.36%+1.33%+417.51%+619.10% 40.49B
-2.29%+5.93%+25.27%+59.26% 34.35B
-2.13%+5.47%+25.45%-6.01% 34.75B
-0.79%+2.02%+3.83%+36.42% 26.98B
+3.82%+3.92% - - 16.58B
-2.62%+0.45%+66.82%+125.87% 15.6B
-2.17%+6.52%+102.15%+102.15% 14.27B
-2.70%-2.19%+11.25%+18.19% 13.76B
Average -0.84%+3.38%+65.28%+96.43% 24.65B
Weighted average by Cap. -1.00%+4.37%+93.71%+139.17%

Financials

2024 2025
Net sales 9.51M 8.33M 7.69M 7.1M 13.47M 909M 13.72M 92.13M 35.85M 446M 35.7M 34.93M 1.55B 7.42M 6.5M 6M 5.55M 10.52M 709M 10.71M 71.93M 27.99M 348M 27.87M 27.27M 1.21B
Net income -1.6M -1.4M -1.29M -1.19M -2.26M -153M -2.31M -15.48M -6.02M -74.88M -6M -5.87M -260M -2.98M -2.61M -2.41M -2.23M -4.23M -285M -4.31M -28.91M -11.25M -140M -11.2M -10.96M -485M
Net Debt -4.15M -3.63M -3.35M -3.1M -5.88M -396M -5.99M -40.2M -15.64M -194M -15.58M -15.24M -675M -3.81M -3.34M -3.08M -2.85M -5.4M -364M -5.5M -36.95M -14.38M -179M -14.32M -14.01M -620M
Logo BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Employees
19
Date Price Change Volume
26-07-08 US$1.930 +1.05% 3,357
26-07-07 US$1.910 -9.05% 6,335
26-07-06 US$2.100 +3.45% 7,523
26-07-02 US$2.030 +1.49% 2,855
26-07-01 US$2.000 +2.57% 2,567
  1. Stock Market
  2. Stocks
  3. BGLC Stock